BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21151389)

  • 1. Selective central nervous system tropism of primary central nervous system lymphoma.
    Jiang L; Marlow LA; Cooper SJ; Roemeling CV; Menke DM; Copland JA; Tun HW
    Int J Clin Exp Pathol; 2010 Oct; 3(8):763-7. PubMed ID: 21151389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
    Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
    Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
    Yuan J; Gu K; He J; Sharma S
    Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of intracerebral lymphoma growth delineated in a syngeneic mouse model of central nervous system lymphoma.
    Montesinos-Rongen M; Sánchez-Ruiz M; Brunn A; Hong K; Bens S; Perales SR; Cigudosa JC; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2013 Apr; 72(4):325-36. PubMed ID: 23481709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
    Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
    Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
    Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
    Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
    Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
    Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.
    Yushi Q; Li Z; Von Roemeling CA; Doeppler H; Marlow LA; Kim BY; Radisky DC; Storz P; Copland JA; Tun HW
    Oncotarget; 2016 May; 7(22):32156-71. PubMed ID: 27050077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma.
    Lim DH; Kim WS; Kim SJ; Yoo HY; Ko YH
    Anticancer Res; 2015 Jun; 35(6):3333-40. PubMed ID: 26026093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report.
    Ma S; Sen SS; Jug R; Zhang X; Zhang WL; Shen S; Yu CQ; Xu HT; Yang LH; Wang E
    Medicine (Baltimore); 2018 Sep; 97(38):e12482. PubMed ID: 30235749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma.
    Isbell LK; Tschuch C; Doostkam S; Waldeck S; Andrieux G; Shoumariyeh K; Lenhard D; Schaefer HE; Reinacher PC; Bartsch I; Pantic M; Vinnakota JM; Kakkassery V; Schorb E; Scherer F; Frey AV; Boerries M; Illerhaus G; Duyster J; Schueler J; von Bubnoff N
    Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12899. PubMed ID: 36879456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of Lymphatic Vessels in PCNSL May Contribute to Confinement of Tumor Cells to the Central Nervous System.
    Deckert M; Brunn A; Montesinos-Rongen M; Siebert R
    J Neuropathol Exp Neurol; 2016 Jun; 75(6):499-502. PubMed ID: 27142645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.
    Cambruzzi E
    World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas.
    Choi JS; Nam DH; Ko YH; Seo JW; Choi YL; Suh YL; Ree HJ
    Am J Surg Pathol; 2003 Jul; 27(7):919-28. PubMed ID: 12826884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease.
    Pouzoulet F; Alentorn A; Royer-Perron L; Assayag F; Mokhtari K; Labiod D; Le Garff-Tavernier M; Daniau M; Menet E; Peyre M; Schnitzler A; Guegan J; Davi F; Hoang-Xuan K; Soussain C
    Blood Cells Mol Dis; 2019 Mar; 75():1-10. PubMed ID: 30502564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
    Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
    Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma.
    Javier R; Shaikh N; Lesniak MS; Sonabend A; Stupp R; Behdad A; Horbinski C
    Diagn Pathol; 2018 Jun; 13(1):37. PubMed ID: 29871654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.